Core Scientific Enters $600 Million Senior Secured Credit Facilities With JPMorgan as Agent
Core Scientific entered into a credit agreement on August 25, 2026, providing a $100 million revolving credit facility and a $500 million letter of credit facility, with no amounts outstanding at closing. The company said the facilities are expected to release about $300 million of restricted cash, which management says will improve capital efficiency and financial flexibility. The agreement is secured by substantially all company assets and carries covenants limiting debt, liens, dividends and share repurchases.
Key points
- Credit agreement dated August 25, 2026, with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent
- $100 million revolving facility matures in three years, or four at the company's election; $500 million letter of credit facility
- Revolver borrowings priced at Adjusted Term SOFR plus 1.75% or alternate base rate plus 0.75%; no amounts outstanding at closing
- Company expects the facilities to release approximately $300 million of restricted cash, per CFO Jim Nygaard
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.